Mawer Investment Management Ltd. lifted its position in CRH Medical Co. (NYSEAMERICAN:CRHM) by 25.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,963,519 shares of the company’s stock after purchasing an additional 1,221,028 shares during the period. Mawer Investment Management Ltd. owned about 8.05% of CRH Medical worth $15,542,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Canada Pension Plan Investment Board grew its stake in CRH Medical by 513.1% during the third quarter. Canada Pension Plan Investment Board now owns 736,350 shares of the company’s stock valued at $1,914,000 after acquiring an additional 616,239 shares in the last quarter. Royal Bank of Canada grew its stake in CRH Medical by 523.9% during the second quarter. Royal Bank of Canada now owns 176,487 shares of the company’s stock valued at $1,006,000 after acquiring an additional 148,200 shares in the last quarter. PDT Partners LLC grew its stake in CRH Medical by 176.4% during the second quarter. PDT Partners LLC now owns 50,162 shares of the company’s stock valued at $285,000 after acquiring an additional 32,013 shares in the last quarter. Stifel Financial Corp grew its stake in shares of CRH Medical by 16.4% in the 2nd quarter. Stifel Financial Corp now owns 1,546,154 shares of the company’s stock worth $8,814,000 after buying an additional 217,672 shares in the last quarter. Finally, Advisor Group Inc. grew its stake in shares of CRH Medical by 35.0% in the 2nd quarter. Advisor Group Inc. now owns 36,177 shares of the company’s stock worth $206,000 after buying an additional 9,389 shares in the last quarter.
A number of equities analysts have commented on the stock. Morgan Stanley raised shares of CRH Medical from an “equal weight” rating to an “overweight” rating in a research note on Friday, November 17th. Zacks Investment Research cut shares of CRH Medical from a “hold” rating to a “sell” rating in a research note on Tuesday, November 14th. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $7.50.
CRH Medical Co. (NYSEAMERICAN CRHM) traded up $0.20 during trading on Thursday, hitting $2.50. 235,902 shares of the stock traded hands, compared to its average volume of 154,426. CRH Medical Co. has a 12-month low of $1.46 and a 12-month high of $9.25.
COPYRIGHT VIOLATION NOTICE: “CRH Medical Co. (NYSEAMERICAN:CRHM) Shares Bought by Mawer Investment Management Ltd.” was originally posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.thelincolnianonline.com/2017/12/08/crh-medical-co-crhm-position-increased-by-mawer-investment-management-ltd-updated-updated.html.
CRH Medical Company Profile
CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.
Receive News & Ratings for CRH Medical Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Co. and related companies with MarketBeat.com's FREE daily email newsletter.